Cathie Wood Sees Value In Tesla Wreckage As Ark Buys $13M Worth Of EV Giant’s Stock, Loads Up On Bitcoin And Ethereum ETFs
As Tesla, Inc. (NASDAQ:TSLA) fell for a fifth straight session on Thursday, breaching a significant psychologica
Has Robinhood Halted 24-Hour Trading? Social Media Explodes With Screenshots And Theories: ‘Tomorrow Is Not Going To Be Pretty’
Robinhood Markets has purportedly ceased 24-hour trading, raising concerns among investors. This action is said to align with the increasing tensions between Iran and Israel.
TSMC Cautions Red-Hot Chip Industry Growth Could Cool Amid Declining Automotive Chip Demand
Taiwan Semiconductor has cautioned that the red-hot growth in the chip industry might be cooling down, citing a potential decline in automotive chip demand.
Microsoft’s Strategic Emphasis on AI and Cloud Services Signals Strong Future Performance: Analysts
Citigroup analyst maintains Microsoft with a Buy and lowered price target from $480 to $475, expecting strong Azure growth, while BofA analyst reiterates Buy with $480 target.
Discover Financial Faces Concerns Over Remediation Reserve, Analysts Caution Despite Q1 Sales Growth
Discover Financial Services faces scrutiny over remediation reserves as analysts express caution despite strong Q1 revenue growth.
IMAX Gaining On All Grounds – Analyst Highlights StreamSmart Technology And Global Expansion as Catalysts
Wedbush analyst Alicia Reese reaffirms Outperform rating on IMAX ahead of Q1 FY24 earnings. Expectations soar with projected revenue and EPS surpassing estimates, highlighting IMAX's global box office success.
Alcoa Well-Positioned To Benefit From Positive Pricing Momentum, Analyst Says
Alcoa receives price target increase from analysts after beating earnings estimates. Alumina production and shipments expected to rise in FY24.
Stocks Edge Higher As Earnings Provide Support, Tesla Sinks To 15-Month Lows, Bitcoin Rebounds: What’s Driving Markets Thursday?
Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the latest wave of corporate earnings.
Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces interim findings and $40 million PIPE financing.
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth buying. Top 5 stocks with biggest gap between price and target: CCL, BIO, WBD, CZR, CCO.